Feline Hyperthyroidism Treatment via Dietary Iodine and Selenium
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for feline hyperthyroidism, such as anti-thyroid medications, surgery, and radioactive iodine therapy, are costly, have side effects, and are not suitable for older cats or those with other diseases, necessitating alternative compositions and methods for effective treatment.
Innovation Solution
Compositions containing 0.1 to 1 mg/kg iodine and 0.1 to 1 mg/kg selenium, optionally combined with antithyroid agents, are used to treat hyperthyroidism in cats, either as food compositions or supplements, which help regulate thyroid hormone production and metabolism.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional anti-thyroid medications are administered orally, then hyperthyroidism treatment is achieved, but compliance is compromised due to cost and side effects
Solution Approach 1:
The patent changes the parameter of administration from oral medication to dietary supplementation through food composition, transforming the delivery mechanism and reducing compliance issues associated with daily medication administration
Solution Approach 2:
The patent uses inexpensive dietary ingredients (iodine and selenium) as a substitute for expensive anti-thyroid medications, providing a cost-effective treatment option that improves compliance
2Reliability
If surgery is performed to remove thyroid glands, then hyperthyroidism is treated, but anesthesia risks and suitability for older felines with other diseases are concerns
Solution Approach 1:
The patent replaces the mechanical surgical intervention with a biochemical treatment approach using dietary supplementation, eliminating the need for anesthesia and surgical procedures
Solution Approach 2:
The patent introduces dietary ingredients (iodine and selenium) as intermediary substances that mediate the treatment effect, providing a non-invasive alternative to direct surgical removal
3Reliability
If radioactive iodine therapy is used, then hyperthyroidism is treated, but facility availability and hospitalization requirements limit accessibility
Solution Approach 1:
The patent extracts the essential treatment mechanism from complex facility-based radioactive iodine therapy, isolating the active ingredients (iodine and selenium) that can be delivered through simple dietary supplementation
Solution Approach 2:
The patent replaces expensive and complex radioactive iodine therapy with inexpensive, stable dietary ingredients that can be administered at home without specialized facilities
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These compositions provide effective partial or complete relief from hyperthyroidism without the side effects of traditional treatments, improving compliance and reducing costs by allowing easy administration through food, while also being suitable for cats with renal insufficiency.
Implementation Method 1
Hyperthyroidism is characterized by hypermetabolism of the thyroid gland and excessive production of the thyroid hormones triiodothyronine (T3) and tetraiodothyronine (thyroxine or T4)
Data Source
AI summary
Methods for treating feline hyperthyroidism comprising (1) administering to a feline an antithyroid agent in conjunction with feeding the feline a composition comprising from about 0.1 to less than about 1 mg/kg iodine or (2) feeding the feline a composition comprising from about 0.1 to less than about 1 mg/kg selenium on a dry matter basis.